Discontinued — last reported Q4 '19
Products & Services · Revenue
ALPROLIX — Revenue
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2016
Last reportedQ4 2019Feb 6, 2020
Rolls up toTotal Revenue
How to read this metric
An increase indicates growing market adoption or improved pricing, while a decrease may signal increased competition, loss of patent exclusivity, or shifts in patient treatment protocols.
Detailed definition
This metric represents the total net sales generated from the commercialization of the specific hemophilia therapy produ...
Peer comparison
Comparable to specialized product revenue lines in other biopharmaceutical companies focused on rare diseases or hematology.
Metric ID:
biib_segment_alprolix_revenuesSimilar Metrics at Other Companies
Frequently Asked Questions
- What does alprolix — revenue mean?
- The total revenue earned from sales of the Alprolix hemophilia treatment.